-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Tracy Cooley
J.P. Morgan Turns All Eyes toward Biotech
BioWorld’s Peter Winter reports that the mood is upbeat at today’s kickoff of the 33rd annual J.P. Morgan Healthcare Conference in San Francisco (check out the story here, subscription required). Winter points to coming off ‘a record year in terms of raising capital, performance on the capital markets and partnering and mergers and acquisitions’ as one reason for the strong momentum at this year’s conference. Looking ahead, Roth Capital Partners’ John Chambers shared with Winter Read More >
CDC: It’s Not Too Late to Get This Season’s Flu Vaccine
Politico Pro’s Brett Norman today writes that the Centers for Disease Control and Prevention (CDC) continues to encourage the public to get the flu vaccine since hospitalizations related to the flu are on the rise. The article states that flu-related hospitalizations of those over 65 jumped to 92 per 100,000 this week, up from 52 last week. “The fact that this season’s flu vaccine is poorly matched with the dominant strains circulating makes it more Read More >
Cervical Health Awareness Month: 5 Things You Need to Know about HPV
Approximately 79 million Americans have HPV (human papillomavirus), which is a major cause of cervical cancer. HPVs are a group of more than 150 related viruses. More than 40 of these viruses can be easily spread through direct skin-to-skin contact. Most infections with high-risk HPVs do not cause cancer. Many HPV infections disappear within two years, but infections lasting several years may increase the risk of developing cancer. High-risk HPV infection accounts for approximately five Read More >
World AIDS Day: Act Aware
World AIDS Day is an opportunity for people worldwide to unite in the fight against HIV, show their support for people living with HIV and commemorate people who have died. World AIDS Day was the first ever global health day and the first one was held in 1988. The theme for this year’s World AIDS Day (Dec. 1) is focused on education on HIV/AIDS awareness and applying this knowledge to encourage protection from HIV infection. Many Read More >
New Survey: Most Women Believe They Are Not up-to-Date on Vaccinations
A new national survey from Rite Aid (NYSE: RAD) and National Foundation for Infectious Diseases (NFID) shows that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. Seventy percent of survey participants reported receiving at least one vaccination in the last five years to prevent disease—most often citing the flu and tetanus vaccines. When asked about a range Read More >
